Publications
-
- Conference presentation
- [ADA 2022] Therapeutic Potential of DA-1726, a Novel Oxyntomodulin Analogue, in a Diet-Induced NASH Mouse Model
-
- Conference presentation
- [ADA 2022] DA-1726, a Balanced GLP1R/GCGR Dual Agonist, Effectively Controls both Body Weight and Blood Glucose
-
- Conference presentation
- [EASD 2021] DA-1241 a novel GPR119 Agonist Data on Safety, Tolerability and Pharmacokinetics (PK), from Part 1 of a Phase 1b Multiple Ascending Dose (MAD) Study in Healthy Volunteers (HV)
-
- Conference presentation
- [EASD 2021] DA-1241 a novel GPR119 Agonist: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics - Part 2 of Multiple Ascending Dose Study in Type 2 Diabetes Patients
-
- Conference presentation
- [ADA 2021] DA-1241 a novel GPR119 Agonist Data on Safety, Tolerability and Pharmacokinetics(PK), from Part 1 of a Phase 1b Multiple Ascending Dose(MAD) Study in Healthy Volunteers(HV)
-
- Conference presentation
- [ADA 2021] DA-1241 a novel GPR119 Agonist: Data on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics from Part 2 of a Phase 1b Multiple Ascending Dose Study in Patients with Type 2 Diabetes Mellitus
-
- Paper publication
- A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects. Drug Des Devel Ther. 2023 Apr 21;17:1203-1210. doi: 10.2147/DDDT.S404182. PMID: 37113469; PMCID: PMC10128151.Kim HC, Lee S, Sung S, Kim E, Jang IJ, Chung JY.
-
- Paper publication
- Synthesis and Evaluation of Dapagliflozin Ester Prodrugs with Improved Hygroscopicity and Thermal Stability. Letters in Drug Design & Discovery, Volume 17, Number 11, 2020, pp. 1409-1421(13) . doi: 10.2174/1570180817999200618162949 Sung SY, Chae YN, Lee DY, Kim KM, Kim EJ, Han JH, Kim WY, Sung-Hwa.
-
- Paper publication
- Absorption, metabolism, and excretion of [14C]evogliptin tartrate in male rats and dogs. J Toxicol Environ Health A. 2018;81(11):453-464. doi: 10.1080/15287394.2018.1451194. Epub 2018 Mar 20. PMID: 29557727.Lee DY, Kim JH, Shim HJ, Jeong HU, Lee HS.
-
- Paper publication
- Additive effects of evogliptin in combination with pioglitazone on fasting glucose control through direct and indirect hepatic effects in diabetic mice. Eur J Pharmacol. 2018 Jul 5;830:95-104. doi: 10.1016/j.ejphar.2018.04.033. Epub 2018 May 1. PMID: 29727638. Kim TH, Lee JH, Chae YN, Jung IH, Kim MK.
